BBW
GILD icon

Blue Barn Wealth’s Gilead Sciences GILD Stock Holding History

Blue Barn Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,160
Closed -$240K – 85
2025
Q3 		$240K Buy
2,160
+13
+0.6% +$1.48K 0.11% 137
2025
Q2 		$238K Buy
2,147
+135
+7% +$14.4K 0.11% 133
2025
Q1 		$225K Buy
+2,012
New +$208K 0.12% 135
2024
Q1 		– Sell
-2,625
Closed -$213K – 139
2023
Q4 		$213K Buy
+2,625
New +$204K 0.13% 111

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Blue Barn Wealth's GILD Position: Q4 2025 in Review

Blue Barn Wealth sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,160 shares — an estimated $240K sold.

Blue Barn Wealth first reported a position in GILD in Q4 2023 and held it in 4 quarters. The position peaked at $240K in Q3 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Blue Barn Wealth reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Blue Barn Wealth sold 2,160 Gilead Sciences shares in Q4 2025, an estimated $240K.
  • Blue Barn Wealth first reported a position in Gilead Sciences in Q4 2023 and held it in 4 quarters.
  • Blue Barn Wealth's Gilead Sciences position peaked at $240K in Q3 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Blue Barn Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.